Expanding antiretroviral therapy in Malawi: Drawing on the country's experience with tuberculosis

British Medical Journal

Volumn 329, Issue 7475, 2004, Pages 1163-1166

  Harries, Anthony D ^a   Libamba, Edwin ^a   Schouten, Erik J ^a   Mwansambo, Andrina ^b   Salaniponi, Felix M ^a   Mpazanje, Rex ^a  

^a MINISTRY OF HEALTH   (Malawi)

^b National AIDS Commission   (Malawi)

Author keywords

[No Author keywords available]

Indexed keywords

DEVELOPING COUNTRY; HEALTH CARE DELIVERY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALAWI; PRIORITY JOURNAL; REVIEW; SHORT COURSE THERAPY; TUBERCULOSIS; TUBERCULOSIS CONTROL;

EID: 8744254741     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.329.7475.1163     Document Type: Review

References (18)

1. UNAIDS, World Health Organization. AIDS epidemic update. Geneva: UNAIDS/WHO, 2003. (UNAIDS/03.39E.)
2. National AIDS Commission. National estimate of HIV/AIDS in Malawi in 2003. Lilongwe, Malawi: National AIDS Commission Malawi 2003,
3. Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998;338:853-60.
4. Mocroft A, Ledergerber B, Katlama C, Kirk O, Reiss P, d'Arminio Monforte A, et al. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet 2003;362:22-9.
5. Chimzizi R, Harries A, Libamba E. Report of a country-wide survey of HIV/ AIDS services in Malawi (for the year 2003). Lilongwe, Malawi: National Tuberculosis Control Programme and HIV/AIDS Unit, Ministry of Health, and National AIDS commission, 2004.
6. Jong-wook L. Global health improvement and WHO: shaping the future. Lancet 2003;362:2083-8.
7. Ministry of Health and Population. Malawi national health accounts: a broader perspective of the Malawian health sector. Lilongwe, Malawi: Ministry of Health, 2001.
8. World Health Organization. Treatment of tuberculosis. Guidelines for national programmes. Geneva: WHO, 2003. (WHO/CDS/TB/2003.313.)
9. World Health Organization. WHO report 2004. Global tuberculosis control surveillance, planning and financing. Geneva: WHO, 2004. (WHO/HTM/ TB/2004.331.)
10. Harries AD, Nyangulu DS, Hargreaves NJ, Kaluwa O, Salaniponi FM. Preventing antiretroviral anarchy in sub-Saharan Africa. Lancet 2001;358:410-4.
11. Ministry of Health and Population. Manual of the national tuberculosis control programme of Malawi. 5th ed. Lilongwe, Malawi: Ministry of Health and Population, 2002.
12. World Health Organization. Scaling up antiretroviral therapy in resource-limited settings: treatment guidelines for a public health approach. Geneva: WHO, 2003. (Revision.)
13. Warndorff DK, Yates M, Ngwira B, Chagaluka S, Jenkins PA, Drobniewski F et al. Trends in antituberculosis drug resistance in Karonga district, Malawi, 1986-1998. Int J Tuberc Lung Dis 2000;4:752-7.
14. Manders AJE, Banerjee A, van den Borne HW, Harries AD, Kok GJ, Salaniponi FML. Can guardians supervise TB treatment as well as health workers? A study on adherence during the intensive phase. Int J Tuberc Lung Dis 2001;5:838-42.
15. Banerjee A, Harries AD, Mphasa N, Nyirenda TE, Veen J, Ringdal T, et al. Evaluation of a unified regimen for all new cases of tuberculosis using guardian-based supervision. Int J Tuberc Lung Dis 2000;4:333-9.
16. Mitty JA, Stone VE, Sands M, Macalino G, Flanigan T. Directly observed therapy for the treatment of people with human immunodeficiency virus infection: a work in progress. Clin Infec Dis 2002;34:984-90.
17. Liechty CA, Bangsberg DR. Doubts about DOT: antiretroviral therapy for resource-poor countries. AIDS 2003;17:1383-7.
18. Stevens W, Kaye S, Corrah T. Antiretroviral therapy in Africa. BMJ 2004:328:280-2.